Charles E Rengifo Selected Research

Lymphoma (Lymphomas)

1/2013

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles E Rengifo Research Topics

Disease

5	Neoplasms (Cancer) 01/2015 - 06/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 01/2012
2	Melanoma (Melanoma, Malignant) 01/2011 - 01/2011
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Carcinoma (Carcinomatosis) 01/2013
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Lymphatic Metastasis 01/2013
1	Lymphoma (Lymphomas) 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Skin Neoplasms (Skin Cancer) 01/2011

Drug/Important Bio-Agent (IBA)

7	G(M3) GangliosideIBA 01/2015 - 01/2011
3	Epidermal Growth Factor (EGF)IBA 01/2015 - 06/2007
3	Monoclonal AntibodiesIBA 01/2013 - 06/2007
2	GangliosidesIBA 01/2013 - 01/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2013 - 06/2007
1	GlycoconjugatesIBA 01/2013
1	AntigensIBA 01/2013
1	N-glycolylneuraminic acidIBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	Heterophile AntigensIBA 01/2013

Therapy/Procedure

3	Immunotherapy 01/2013 - 01/2011